BioCardia, Inc. Warrant
BCDAW
BCDAW was delisted on the 2nd of August, 2024.
2 hedge funds and large institutions have $348K invested in BioCardia, Inc. Warrant in 2020 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
13% more capital invested
Capital invested by funds: $309K → $348K (+$39K)
33% less funds holding
Funds holding: 3 → 2 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
+$1.3K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $310K | – | – | – |
|
|
2
Osaic Holdings
Scottsdale,
Arizona
| $38K | +$1.3K | +1,912 | +3% |
|
BCDAW Hedge Fund Activity: Q3 2020 in Review
2 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in BioCardia, Inc. Warrant (BCDAW) for Q3 2020, worth a combined $348K — up 13% from $309K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BCDAW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was Osaic Holdings, adding an estimated $1.3K.
- 2 institutional investors held BioCardia, Inc. Warrant (BCDAW) as of Q3 2020, down from 3 in Q2 2020.
- Funds reported $348K of BioCardia, Inc. Warrant stock for Q3 2020, up 13% quarter-over-quarter.
- 0 funds opened new BioCardia, Inc. Warrant positions in Q3 2020 and 1 closed out, a net change of -1 holder.
- The largest BioCardia, Inc. Warrant buyer in Q3 2020 was Osaic Holdings, an estimated $1.3K added.
Based on aggregated 13F filings for Q3 2020.